Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NON-INVASIVE GLUCOSE METER MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NON-INVASIVE GLUCOSE METER MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VALUE AND VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL NON-INVASIVE GLUCOSE METER MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 MANUAFCTURING AND R&D ANALYSIS
16.1 R&D ANALYSIS
16.2 BLOOD-SUGAR DETECTION VIA MONITORING
16.2.1 ACETONE CONTENTS IN BREATH
16.2.2 KETONE CONTENTS IN BREATH
16.2.3 OTHERS
16.3 MANUFACTURING PROCESS NONINVASIVE GLUCOMETERS
16.3.1 ACETONE CONTENTS IN BREATH
16.3.2 KETONE CONTENTS IN BREATH
16.3.3 OTHERS
17 EPIDEMIOLOGY
17.1 PREVALENCE AND INCIDENCE OF DIABETES, BY COUNTRY
17.2 PREVALENCE AND INCIDENCE OF DIABETES, BY AGE GROUP
18 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY PRODUCT TYPE
18.1 OVERVIEW
18.2 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
18.2.1 BY TYPE
18.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
18.2.1.1.1. MONITORING PATCHES
18.2.1.1.1.1 FABRIC PATCHES
18.2.1.1.1.2 OTHERS
18.2.1.1.2. CONTINUOUS MONITORING SENSORS
18.2.1.1.3. SMART LENSES
18.2.1.1.4. SMART WATCHES
18.2.1.1.5. OTHERS
18.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
18.2.1.2.1. TABLE TOP
18.2.1.2.2. HANDHELD
18.2.1.2.3. OTHERS
18.2.2 BY TECHNOLOGY
18.2.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)
18.2.2.2. POLARIZED OPTICAL ROTATION
18.2.2.3. RAMAN SPECTROSCOPY
18.2.2.4. FLUORESCENCE
18.2.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)
18.2.2.6. OTHERS
18.3 NONINVASIVE FLUID SAMPLING (NIFS-GM)
18.3.1 BY TYPE
18.3.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
18.3.1.1.1. MONITORING PATCHES
18.3.1.1.1.1 FABRIC PATCHES
18.3.1.1.1.2 OTHERS
18.3.1.1.2. CONTINUOUS MONITORING SENSORS
18.3.1.1.3. SMART LENSES
18.3.1.1.4. SMART WATCHES
18.3.1.1.5. OTHERS
18.3.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
18.3.1.2.1. TABLE TOP
18.3.1.2.2. HANDHELD
18.3.1.2.3. OTHERS
18.3.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL
18.3.1.3.1. SWNT-CS-GNP
18.3.1.3.2. PTB-GOX
18.3.1.3.3. NANO-GOLD
18.3.2 BY TECHNOLOGY
18.3.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING
18.3.2.2. TEAR-BASED GLUCOSE MONITORING
18.3.2.3. SWEAT-BASED GLUCOSE MONITORING
18.3.2.4. ISF-BASED GLUCOSE MONITORING
18.3.2.5. OTHERS
18.4 OTHERS
19 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY SITE
19.1 OVERVIEW
19.2 ARM/ WRIST
19.2.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
19.2.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
19.2.3 OTHERS
19.3 EAR LOBE
19.3.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
19.3.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
19.3.3 OTHERS
19.4 FOREFINGER AND THUMB
19.4.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
19.4.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
19.4.3 OTHERS
19.5 CORNEA/ EYE LID
19.5.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
19.5.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
19.5.3 OTHERS
19.6 OTHERS
20 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY APPLICATION
20.1 OVERVIEW
20.2 INTENSIVE INSULIN THERAPY
20.2.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
20.2.1.1. BY TYPE
20.2.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.2.1.1.1.1 MONITORING PATCHES
20.2.1.1.1.1.1. FABRIC PATCHES
20.2.1.1.1.1.2. OTHERS
20.2.1.1.1.2 CONTINUOUS MONITORING SENSORS
20.2.1.1.1.3 SMART LENSES
20.2.1.1.1.4 SMART WATCHES
20.2.1.1.1.5 OTHERS
20.2.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.2.1.1.2.1 TABLE TOP
20.2.1.1.2.2 HANDHELD
20.2.1.1.2.3 OTHERS
20.2.1.2. BY TECHNOLOGY
20.2.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)
20.2.1.2.2. POLARIZED OPTICAL ROTATION
20.2.1.2.3. RAMAN SPECTROSCOPY
20.2.1.2.4. FLUORESCENCE
20.2.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)
20.2.1.2.6. OTHERS
20.2.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
20.2.2.1. BY TYPE
20.2.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.2.2.1.1.1 MONITORING PATCHES
20.2.2.1.1.1.1. FABRIC PATCHES
20.2.2.1.1.1.2. OTHERS
20.2.2.1.1.2 CONTINUOUS MONITORING SENSORS
20.2.2.1.1.3 SMART LENSES
20.2.2.1.1.4 SMART WATCHES
20.2.2.1.1.5 OTHERS
20.2.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.2.2.1.2.1 TABLE TOP
20.2.2.1.2.2 HANDHELD
20.2.2.1.2.3 OTHERS
20.2.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL
20.2.2.1.3.1 SWNT-CS-GNP
20.2.2.1.3.2 PTB-GOX
20.2.2.1.3.3 NANO-GOLD
20.2.2.2. BY TECHNOLOGY
20.2.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING
20.2.2.2.2. TEAR-BASED GLUCOSE MONITORING
20.2.2.2.3. SWEAT-BASED GLUCOSE MONITORING
20.2.2.2.4. ISF-BASED GLUCOSE MONITORING
20.2.2.2.5. OTHERS
20.2.3 OTHERS
20.3 HYPOGLYCEMIA
20.3.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
20.3.1.1. BY TYPE
20.3.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.3.1.1.1.1 MONITORING PATCHES
20.3.1.1.1.1.1. FABRIC PATCHES
20.3.1.1.1.1.2. OTHERS
20.3.1.1.1.2 CONTINUOUS MONITORING SENSORS
20.3.1.1.1.3 SMART LENSES
20.3.1.1.1.4 SMART WATCHES
20.3.1.1.1.5 OTHERS
20.3.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.3.1.1.2.1 TABLE TOP
20.3.1.1.2.2 HANDHELD
20.3.1.1.2.3 OTHERS
20.3.1.2. BY TECHNOLOGY
20.3.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)
20.3.1.2.2. POLARIZED OPTICAL ROTATION
20.3.1.2.3. RAMAN SPECTROSCOPY
20.3.1.2.4. FLUORESCENCE
20.3.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)
20.3.1.2.6. OTHERS
20.3.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
20.3.2.1. BY TYPE
20.3.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.3.2.1.1.1 MONITORING PATCHES
20.3.2.1.1.1.1. FABRIC PATCHES
20.3.2.1.1.1.2. OTHERS
20.3.2.1.1.2 CONTINUOUS MONITORING SENSORS
20.3.2.1.1.3 SMART LENSES
20.3.2.1.1.4 SMART WATCHES
20.3.2.1.1.5 OTHERS
20.3.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.3.2.1.2.1 TABLE TOP
20.3.2.1.2.2 HANDHELD
20.3.2.1.2.3 OTHERS
20.3.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL
20.3.2.1.3.1 SWNT-CS-GNP
20.3.2.1.3.2 PTB-GOX
20.3.2.1.3.3 NANO-GOLD
20.3.2.2. BY TECHNOLOGY
20.3.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING
20.3.2.2.2. TEAR-BASED GLUCOSE MONITORING
20.3.2.2.3. SWEAT-BASED GLUCOSE MONITORING
20.3.2.2.4. ISF-BASED GLUCOSE MONITORING
20.3.2.2.5. OTHERS
20.3.3 OTHERS
20.4 DIABETIC FOOT ULCER TRACKING
20.4.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)
20.4.1.1. BY TYPE
20.4.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.4.1.1.1.1 MONITORING PATCHES
20.4.1.1.1.1.1. FABRIC PATCHES
20.4.1.1.1.1.2. OTHERS
20.4.1.1.1.2 CONTINUOUS MONITORING SENSORS
20.4.1.1.1.3 SMART LENSES
20.4.1.1.1.4 SMART WATCHES
20.4.1.1.1.5 OTHERS
20.4.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.4.1.1.2.1 TABLE TOP
20.4.1.1.2.2 HANDHELD
20.4.1.1.2.3 OTHERS
20.4.1.2. BY TECHNOLOGY
20.4.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)
20.4.1.2.2. POLARIZED OPTICAL ROTATION
20.4.1.2.3. RAMAN SPECTROSCOPY
20.4.1.2.4. FLUORESCENCE
20.4.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)
20.4.1.2.6. OTHERS
20.4.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)
20.4.2.1. BY TYPE
20.4.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS
20.4.2.1.1.1 MONITORING PATCHES
20.4.2.1.1.1.1. FABRIC PATCHES
20.4.2.1.1.1.2. OTHERS
20.4.2.1.1.2 CONTINUOUS MONITORING SENSORS
20.4.2.1.1.3 SMART LENSES
20.4.2.1.1.4 SMART WATCHES
20.4.2.1.1.5 OTHERS
20.4.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS
20.4.2.1.2.1 TABLE TOP
20.4.2.1.2.2 HANDHELD
20.4.2.1.2.3 OTHERS
20.4.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL
20.4.2.1.3.1 SWNT-CS-GNP
20.4.2.1.3.2 PTB-GOX
20.4.2.1.3.3 NANO-GOLD
20.4.2.2. BY TECHNOLOGY
20.4.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING
20.4.2.2.2. TEAR-BASED GLUCOSE MONITORING
20.4.2.2.3. SWEAT-BASED GLUCOSE MONITORING
20.4.2.2.4. ISF-BASED GLUCOSE MONITORING
20.4.2.2.5. OTHERS
20.4.3 OTHERS
20.5 OTHERS
21 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY END USER
21.1 OVERVIEW
21.2 HOSPITALS
21.2.1 PUBLIC
21.2.2 PRIVATE
21.3 SPECIALITY CLINICS
21.4 DIAGNOSTIC CENTRES
21.5 HOME CARE SETTINGS
21.6 AMBULATORY SURGICAL CENTERS
21.7 ACADEMIC & RESEARCH INSTITUTES
21.8 OTHERS
22 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY DISTRIBUTION CHANNEL
22.1 OVERVIEW
22.2 DIRECT TENDER
22.3 RETAIL SALES
22.3.1 ONLINE SALES
22.3.2 OFFLINE SALES
22.4 OTHERS
23 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY GEOGRAPHY
GLOBAL NON-INVASIVE GLUCOSE METER MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 NORTH AMERICA
23.1.1 U.S.
23.1.2 CANADA
23.1.3 MEXICO
23.2 EUROPE
23.2.1 GERMANY
23.2.2 FRANCE
23.2.3 U.K.
23.2.4 ITALY
23.2.5 SPAIN
23.2.6 RUSSIA
23.2.7 TURKEY
23.2.8 BELGIUM
23.2.9 NETHERLANDS
23.2.10 SWITZERLAND
23.2.11 REST OF EUROPE
23.3 ASIA-PACIFIC
23.3.1 JAPAN
23.3.2 CHINA
23.3.3 SOUTH KOREA
23.3.4 INDIA
23.3.5 AUSTRALIA
23.3.6 SINGAPORE
23.3.7 THAILAND
23.3.8 MALAYSIA
23.3.9 INDONESIA
23.3.10 PHILIPPINES
23.3.11 REST OF ASIA-PACIFIC
23.4 SOUTH AMERICA
23.4.1 BRAZIL
23.4.2 ARGENTINA
23.4.3 REST OF SOUTH AMERICA
23.5 MIDDLE EAST AND AFRICA
23.5.1 SOUTH AFRICA
23.5.2 SAUDI ARABIA
23.5.3 UAE
23.5.4 EGYPT
23.5.5 ISRAEL
23.5.6 REST OF MIDDLE EAST AND AFRICA
23.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: GLOBAL
25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.3 COMPANY SHARE ANALYSIS: EUROPE
25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
25.5 MERGERS & ACQUISITIONS
25.6 NEW PRODUCT DEVELOPMENT & APPROVALS
25.7 EXPANSIONS
25.8 REGULATORY CHANGES
25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, COMPANY PROFILE
26.1 ABBOTT
26.1.1 COMPANY OVERVIEW
26.1.2 REVENUE ANALYSIS
26.1.3 GEOGRAPHIC PRESENCE
26.1.4 PRODUCT PORTFOLIO
26.1.5 RECENT DEVELOPMENTS
26.2 ASCENSIA DIABETES CARE HOLDINGS AG (PHC HOLDINGS CORPORATION)
26.2.1 COMPANY OVERVIEW
26.2.2 REVENUE ANALYSIS
26.2.3 GEOGRAPHIC PRESENCE
26.2.4 PRODUCT PORTFOLIO
26.2.5 RECENT DEVELOPMENTS
26.3 DEXCOM, INC.
26.3.1 COMPANY OVERVIEW
26.3.2 REVENUE ANALYSIS
26.3.3 GEOGRAPHIC PRESENCE
26.3.4 PRODUCT PORTFOLIO
26.3.5 RECENT DEVELOPMENTS
26.4 MEDTRONIC
26.4.1 COMPANY OVERVIEW
26.4.2 REVENUE ANALYSIS
26.4.3 GEOGRAPHIC PRESENCE
26.4.4 PRODUCT PORTFOLIO
26.4.5 RECENT DEVELOPMENTS
26.5 INTEGRITY APPLICATIONS
26.5.1 COMPANY OVERVIEW
26.5.2 REVENUE ANALYSIS
26.5.3 GEOGRAPHIC PRESENCE
26.5.4 PRODUCT PORTFOLIO
26.5.5 RECENT DEVELOPMENTS
26.6 DIAMONTECH AG
26.6.1 COMPANY OVERVIEW
26.6.2 REVENUE ANALYSIS
26.6.3 GEOGRAPHIC PRESENCE
26.6.4 PRODUCT PORTFOLIO
26.6.5 RECENT DEVELOPMENTS
26.7 CNOGA
26.7.1 COMPANY OVERVIEW
26.7.2 REVENUE ANALYSIS
26.7.3 GEOGRAPHIC PRESENCE
26.7.4 PRODUCT PORTFOLIO
26.7.5 RECENT DEVELOPMENTS
26.8 BOYDSENSE SAS
26.8.1 COMPANY OVERVIEW
26.8.2 REVENUE ANALYSIS
26.8.3 GEOGRAPHIC PRESENCE
26.8.4 PRODUCT PORTFOLIO
26.8.5 RECENT DEVELOPMENTS
26.9 META MATERIALS INC.
26.9.1 COMPANY OVERVIEW
26.9.2 REVENUE ANALYSIS
26.9.3 GEOGRAPHIC PRESENCE
26.9.4 PRODUCT PORTFOLIO
26.9.5 RECENT DEVELOPMENTS
26.1 OPTICOLOGY INC.
26.10.1 COMPANY OVERVIEW
26.10.2 REVENUE ANALYSIS
26.10.3 GEOGRAPHIC PRESENCE
26.10.4 PRODUCT PORTFOLIO
26.10.5 RECENT DEVELOPMENTS
26.11 HAGAR TECHNOLOGY
26.11.1 COMPANY OVERVIEW
26.11.2 REVENUE ANALYSIS
26.11.3 GEOGRAPHIC PRESENCE
26.11.4 PRODUCT PORTFOLIO
26.11.5 RECENT DEVELOPMENTS
26.12 NEMAURA
26.12.1 COMPANY OVERVIEW
26.12.2 REVENUE ANALYSIS
26.12.3 GEOGRAPHIC PRESENCE
26.12.4 PRODUCT PORTFOLIO
26.12.5 RECENT DEVELOPMENTS
26.13 KNOW LABS, INC.
26.13.1 COMPANY OVERVIEW
26.13.2 REVENUE ANALYSIS
26.13.3 GEOGRAPHIC PRESENCE
26.13.4 PRODUCT PORTFOLIO
26.13.5 RECENT DEVELOPMENTS
26.14 NOVIOSENSE
26.14.1 COMPANY OVERVIEW
26.14.2 REVENUE ANALYSIS
26.14.3 GEOGRAPHIC PRESENCE
26.14.4 PRODUCT PORTFOLIO
26.14.5 RECENT DEVELOPMENTS
26.15 LIFEPLUS
26.15.1 COMPANY OVERVIEW
26.15.2 REVENUE ANALYSIS
26.15.3 GEOGRAPHIC PRESENCE
26.15.4 PRODUCT PORTFOLIO
26.15.5 RECENT DEVELOPMENTS
26.16 AFON TECHNOLOGY
26.16.1 COMPANY OVERVIEW
26.16.2 REVENUE ANALYSIS
26.16.3 GEOGRAPHIC PRESENCE
26.16.4 PRODUCT PORTFOLIO
26.16.5 RECENT DEVELOPMENTS
26.17 OCCUITY
26.17.1 COMPANY OVERVIEW
26.17.2 REVENUE ANALYSIS
26.17.3 GEOGRAPHIC PRESENCE
26.17.4 PRODUCT PORTFOLIO
26.17.5 RECENT DEVELOPMENTS
26.18 ESER COMPANY
26.18.1 COMPANY OVERVIEW
26.18.2 REVENUE ANALYSIS
26.18.3 GEOGRAPHIC PRESENCE
26.18.4 PRODUCT PORTFOLIO
26.18.5 RECENT DEVELOPMENTS
26.19 ETOUCHUS PVT LTD.
26.19.1 COMPANY OVERVIEW
26.19.2 REVENUE ANALYSIS
26.19.3 GEOGRAPHIC PRESENCE
26.19.4 PRODUCT PORTFOLIO
26.19.5 RECENT DEVELOPMENTS
26.2 VIVALYF INNOVATIONS
26.20.1 COMPANY OVERVIEW
26.20.2 REVENUE ANALYSIS
26.20.3 GEOGRAPHIC PRESENCE
26.20.4 PRODUCT PORTFOLIO
26.20.5 RECENT DEVELOPMENTS
26.21 GLUCOACTIVE LTD.
26.21.1 COMPANY OVERVIEW
26.21.2 REVENUE ANALYSIS
26.21.3 GEOGRAPHIC PRESENCE
26.21.4 PRODUCT PORTFOLIO
26.21.5 RECENT DEVELOPMENTS
26.22 RSP SYSTEMS A/S
26.22.1 COMPANY OVERVIEW
26.22.2 REVENUE ANALYSIS
26.22.3 GEOGRAPHIC PRESENCE
26.22.4 PRODUCT PORTFOLIO
26.22.5 RECENT DEVELOPMENTS
26.23 AERBETIC
26.23.1 COMPANY OVERVIEW
26.23.2 REVENUE ANALYSIS
26.23.3 GEOGRAPHIC PRESENCE
26.23.4 PRODUCT PORTFOLIO
26.23.5 RECENT DEVELOPMENTS
26.24 SINOCARE
26.24.1 COMPANY OVERVIEW
26.24.2 REVENUE ANALYSIS
26.24.3 GEOGRAPHIC PRESENCE
26.24.4 PRODUCT PORTFOLIO
26.24.5 RECENT DEVELOPMENTS
26.25 IGLUCO TECH, S.L.
26.25.1 COMPANY OVERVIEW
26.25.2 REVENUE ANALYSIS
26.25.3 GEOGRAPHIC PRESENCE
26.25.4 PRODUCT PORTFOLIO
26.25.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
